Personalis, Inc. (PSNL)
15.70
-0.16
(-0.98%)
USD |
NASDAQ |
Nov 13, 16:00
15.70
0.00 (0.00%)
After-Hours: 19:59
Personalis Net Income (Quarterly) : -33.80M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -33.80M |
| June 30, 2026 | -31.68M |
| March 31, 2026 | -30.03M |
| December 31, 2025 | -23.81M |
| September 30, 2025 | -21.65M |
| June 30, 2025 | -20.06M |
| March 31, 2025 | -15.75M |
| December 31, 2024 | -16.42M |
| September 30, 2024 | -39.09M |
| June 30, 2024 | -12.80M |
| March 31, 2024 | -12.97M |
| December 31, 2023 | -26.58M |
| September 30, 2023 | -29.10M |
| June 30, 2023 | -23.96M |
| March 31, 2023 | -28.66M |
| December 31, 2022 | -31.07M |
| September 30, 2022 | -26.49M |
| June 30, 2022 | -27.55M |
| Date | Value |
|---|---|
| March 31, 2022 | -28.21M |
| December 31, 2021 | -20.20M |
| September 30, 2021 | -17.67M |
| June 30, 2021 | -14.95M |
| March 31, 2021 | -12.40M |
| December 31, 2020 | -13.34M |
| September 30, 2020 | -9.545M |
| June 30, 2020 | -9.255M |
| March 31, 2020 | -9.139M |
| December 31, 2019 | -6.645M |
| September 30, 2019 | -6.885M |
| June 30, 2019 | -5.869M |
| March 31, 2019 | -5.685M |
| December 31, 2018 | -3.555M |
| September 30, 2018 | -3.641M |
| June 30, 2018 | -7.315M |
| March 31, 2018 | -5.375M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tempus AI, Inc. | -14.85M |
| 10X Genomics, Inc. | -19.42M |
| Alamar Biosciences, Inc. (California) | -13.34M |
| Champions Oncology, Inc. | -0.426M |
| Medpace Holdings, Inc. | 137.46M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 25.60M |
| Total Expenses (Quarterly) | 59.40M |
| EPS Diluted (Quarterly) | -0.3153 |
| Enterprise Value | 1.565B |
| Gross Profit Margin (Quarterly) | 25.67% |
| Profit Margin (Quarterly) | -132.1% |
| Earnings Yield | -7.40% |
| Normalized Earnings Yield | -7.400 |